Application 077722
- Type
- ANDA
- Sponsor
- CHARTWELL RX
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CILOSTAZOL | CILOSTAZOL | TABLET;ORAL | 50MG | No | No |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A077722-001 | CILOSTAZOL | 50MG | TABLET / ORAL | AB | 2012-09-24 | 74a2ff9319b5… | |
| 2019-12-14 00:12 UTC | 2019-12 | A077722-001 | CILOSTAZOL | 50MG | TABLET / ORAL | AB | 2012-09-24 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | A077722-001 | CILOSTAZOL | 50MG | TABLET / ORAL | AB | 2012-09-24 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | A077722-001 | CILOSTAZOL | 50MG | TABLET / ORAL | AB | 2012-09-24 | ea99ee380514… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A077722-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-14 00:12 UTC | 2019-12 | A077722-001 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A077722-001 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A077722-001 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| cilostazol | CILOSTAZOL | Apotex Corp. | ceac1ae3-c343-28ca-c083-b748d21a15e6 | 2026-09-10 | Boxed warning, Warnings, Adverse reactions | cilostazol CILOSTAZOL |
| cilostazol | CILOSTAZOL | AvKARE | dc7c2c25-36a1-e3fd-e053-2995a90adabc | 2026-01-14 | Boxed warning, Warnings, Adverse reactions | cilostazol CILOSTAZOL |
| cilostazol | CILOSTAZOL | AvPAK | aec462c8-e225-f520-cae5-80049151c0ff | 2026-01-06 | Boxed warning, Warnings, Adverse reactions | cilostazol CILOSTAZOL |
| Cilostazol | CILOSTAZOL | Slate Run Pharmaceuticals, LLC | db0278e9-4ece-4aaf-9216-6bcbec58206a | 2025-12-12 | Boxed warning, Warnings, Adverse reactions | Cilostazol CILOSTAZOL |
| Cilostazol | CILOSTAZOL | Chartwell RX, LLC | 77e77eaf-5556-43ac-844e-c0e29f02fe07 | 2025-09-04 | Boxed warning, Warnings, Adverse reactions | Cilostazol CILOSTAZOL |
| CILOSTAZOL | CILOSTAZOL | direct rx | b57d3c1e-e36f-5255-e053-2a95a90ada83 | 2025-01-17 | Boxed warning, Warnings, Adverse reactions | CILOSTAZOL CILOSTAZOL |
| Cilostazol | CILOSTAZOL | Bryant Ranch Prepack | f728395c-684c-4087-a389-c323dbcb72dd | 2024-08-06 | Boxed warning, Warnings, Adverse reactions | Cilostazol CILOSTAZOL |
| cilostazol | CILOSTAZOL | Aphena Pharma Solutions - Tennessee, LLC | 15ead884-bd4f-7f4b-e063-6394a90a8f81 | 2024-04-12 | Boxed warning, Warnings, Adverse reactions | cilostazol CILOSTAZOL |
| cilostazol | CILOSTAZOL | Aphena Pharma Solutions - Tennessee, LLC | 15478d90-312f-014e-e063-6294a90ae838 | 2024-04-04 | Boxed warning, Warnings, Adverse reactions | cilostazol CILOSTAZOL |
| Cilostazol | CILOSTAZOL | Bryant Ranch Prepack | 53486382-eee0-4cbe-bc4a-a57484e0d5a7 | 2024-01-11 | Boxed warning, Warnings, Adverse reactions | Cilostazol CILOSTAZOL |
| Cilostazol | CILOSTAZOL | Teva Pharmaceuticals USA, Inc. | a6292311-9cb2-49ff-b8bf-12e2dbd196cd | 2022-07-31 | Boxed warning, Warnings, Adverse reactions | Cilostazol CILOSTAZOL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.